AGAMREE
Total Payments
$300,501
Transactions
865
Doctors
460
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $288,863 | 855 | 460 |
| 2023 | $11,638 | 10 | 2 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $193,000 | 45 | 64.2% |
| Travel and Lodging | $43,247 | 146 | 14.4% |
| Food and Beverage | $23,448 | 588 | 7.8% |
| Consulting Fee | $22,000 | 5 | 7.3% |
| Unspecified | $16,193 | 1 | 5.4% |
| Education | $1,612 | 79 | 0.5% |
| Grant | $1,000 | 1 | 0.3% |
Payments by Type
General
$284,308
864 transactions
Research
$16,193
1 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| REGISTRY STUDY TO OBSERVE LONG-TERM SAFETY OF VAMOROLONE (AGAMREE) IN PATIENTS WITH DUCHENNE MUSCULAR DYSTROPHY | CATALYST PHARMACEUTICALS, INC. | $16,193 | 0 |
Top Doctors Receiving Payments for AGAMREE
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Salt Lake City, UT | $17,193 | 2 |
| , MD | Pediatrics | Durham, NC | $15,684 | 15 |
| , M.D | Neurology with Special Qualifications in Child Neurology | Miami, FL | $15,467 | 15 |
| , MD | Neurology with Special Qualifications in Child Neurology | Little Rock, AR | $14,229 | 13 |
| , M.D | Pediatrics | Cincinnati, OH | $13,245 | 18 |
| , M.D | Pediatrics | Los Angeles, CA | $12,228 | 12 |
| , MD | Neurology with Special Qualifications in Child Neurology | Seattle, WA | $12,092 | 17 |
| , MD | Neuromuscular Medicine | Los Angeles, CA | $11,139 | 13 |
| Omer Abdul Hamid | Neuromuscular Medicine | Orlando, FL | $7,548 | 13 |
| , MD | Specialist | Philadelphia, PA | $7,529 | 8 |
| , MD | Neurology with Special Qualifications in Child Neurology | Chicago, IL | $7,407 | 6 |
| , MD | Neuromuscular Medicine | Charlotte, NC | $7,397 | 7 |
| , MD | Neurology with Special Qualifications in Child Neurology | Baltimore, MD | $7,376 | 7 |
| , MD | Pediatrics | Pittsburgh, PA | $7,106 | 4 |
| , MD | Neurology with Special Qualifications in Child Neurology | Houston, TX | $7,077 | 5 |
| , MD | Pediatrics | Rochester, MN | $7,017 | 6 |
| , MD | Neuromuscular Medicine | Cincinnati, OH | $5,605 | 11 |
| , M.D | Neurology with Special Qualifications in Child Neurology | Chicago, IL | $5,419 | 7 |
| , M.D., PHD | Pediatrics | Saint Louis, MO | $5,403 | 13 |
| , PNP | Pediatrics | Portland, OR | $5,284 | 10 |
| , M.D | Student in an Organized Health Care Education/Training Program | Hershey, PA | $5,222 | 7 |
| , MD | Vascular Neurology | Rochester, NY | $5,143 | 13 |
| , M.D | Physical Medicine & Rehabilitation | Akron, OH | $5,058 | 14 |
| , M.D | Neurology with Special Qualifications in Child Neurology | Akron, OH | $5,037 | 11 |
| , MD | Clinical Neurophysiology | Owensboro, KY | $5,004 | 14 |
Ad
Manufacturing Companies
- CATALYST PHARMACEUTICALS, INC. $288,863
- Catalyst Pharmaceuticals, Inc. $11,638
Product Information
- Type Drug
- Total Payments $300,501
- Total Doctors 460
- Transactions 865
About AGAMREE
AGAMREE is a drug associated with $300,501 in payments to 460 healthcare providers, recorded across 865 transactions in the CMS Open Payments database. The primary manufacturer is Catalyst Pharmaceuticals, Inc..
Payment data is available from 2023 to 2024. In 2024, $288,863 was paid across 855 transactions to 460 doctors.
The most common payment nature for AGAMREE is "Honoraria" ($193,000, 64.2% of total).
AGAMREE is associated with 1 research study, including "REGISTRY STUDY TO OBSERVE LONG-TERM SAFETY OF VAMOROLONE (AGAMREE) IN PATIENTS WITH DUCHENNE MUSCULAR DYSTROPHY" ($16,193).